TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARCT

Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

16.00$ -5.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Arcturus Therapeutics Holdings Inc (ARCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -74 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARCT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-28 -18 -19 -0.5 -21 -6.4 -43 -135 32 -18 -60 -74
0.0 0.1 0.1 0.4 0.6 0.7 0.9 1.2 1.5 3.0 3.5 3.0
4.1 2.4 2.5 2.2 1.3 2.0 6.8 29 31 35 38 25
4.1 0.3 0.8 2.7 1.6 2.9 6.8 36
0.4 -1.1 2.7 7.4 -1.2 16 21 33 -13 7.4 -21 -39
0.1 0.2 0.1 0.3 1.5 0.8 1.7 3.4 7.7 2.9 0.6 0.2
8.4 -34 4.9 10 22 -0.8 -1.7 -3.4 -7.7 -2.9 -0.6 -0.2
66 66 1.3 1.3 0.3 37 427 1.4
1.9 5.7 5.7 9.9 4.9 47 47 -5.0 -27 0.0 0.0
66 66 0.0 7.0 10 42 436 48 -2.9 -24 5.4 13
-20 14 -14 17 12 35 392 -90 21 -45 -55 -61
-28 -18 -19 -0.7 -22 -7.3 -45 -138 24 -21 -60 -74

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?